specificity (Sp) are often missing. This paper aims to describe and analyse the results obtained 30 with the diagnostics used in Belgium during the 2006 BT crisis. The diagnosis was based on a 31 combination of antibody detection (competitive ELISA, cELISA) and viral RNA detection by 32 real-time RT-PCR (RT-qPCR). The performance of the cELISA as a diagnostic tool was 33 assessed on field results obtained during the epidemic and previous surveillance campaigns. 34 As the infectious status of the animals is unknown during an epidemic, a Bayesian analysis 35 was performed. Both assays were found to be equally specific (RT-qPCR: 98.5%; cELISA: 36 98.2%) while the diagnostic sensitivity of the RT-qPCR (99.5%) was superior to that of the 37 cELISA (87.8%). The assumption of RT-qPCR as standard of comparison during the BTV 38 epidemic proved valid based on the results of the Bayesian analysis. A ROC analysis of the 39 cELISA, using RT-qPCR as standard of comparison, showed that the cut-off point with the 40 highest accuracy occurred at a percentage negativity of 66, which is markedly higher than the 41 cut-off proposed by the manufacturer. The analysis of the results was further extended to 42 serological and molecular profiling and the possible use of profiling as a rapid 43 epidemiological marker of the BTV in-field situation was assessed. A comparison of the 44 serological profiles obtained before, during and at the end of the Belgian epidemic clearly 45 showed the existence of an intermediate zone which appears soon after BTV (re)enters the 46 population. The appearance or disappearance of this intermediate zone is correlated with virus 47 circulation and provides valuable information, which would be entirely overlooked if only 48 positive and negative results were considered. 49 50 A c c e p t e d M a n u s c r i p t 6/30 areas (Calistri et al., 2004; MacLachlan and Osburn, 2006) . As with all other former list A 78 diseases of the World Organisation for Animal Health (OIE -Office International des 79 Epizooties), fast and reliable diagnostic tools are essential in controlling BT. Over the past 80 decades, various serological (agar gel immunodiffusion, competitive ELISA (cELISA)) and 81 virological (virus isolation, RT-PCR) methods have been described and recognised by the 82 OIE (OIE, 2004) as prescribed or alternative tests. Although the validation process 83 recommended by the OIE clearly identifies 5 stages (OIE, 2004 -Chapter 1.1.3. adopted May 84 2006), validation of most diagnostic tests is limited to the first two stages: i) essential 85 prerequisites such as checking the 'fit for purpose', the feasibility and the normalisation of 86 results and ii) part 1 of assay validation with determination of repeatability and analytical 87 sensitivity and specificity. Especially, data on the diagnostic sensitivity and diagnostic 88 specificity are often missing which hampers the evaluation of the test accuracy. For epizootic 89 diseases, like BT, both false positive and false negative results are of great concern to 90 international trade (De Clercq, 1995) . Other major constraints to the validation process of BT 91 diagnostics are the lack of an easy-to-use gold standard (now defined as 'standard of 92 comparison' by OIE) for reliable detection of infectious virus in infected animals and the fact 93 that the detection of specific anti-BTV antibodies or BTV-RNA does not necessarily imply 94 the presence of infectious BTV (Katz et al., 1994; MacLachlan, 2004) . BT clinical signs (suspicion) were analysed with a commercial cELISA and/or a RT-qPCR, 118 respectively (see 2.2.). In total 674 samples were tested in both assays and used to determine 119 the relative sensitivity and specificity (test validation). All samples were used for analysing 120 the frequency distribution of the antibody response values and the RNA levels (profiling). In 121 addition to these serum and blood samples, a wide variety of tissue samples such as spleen, 122 lymph nodes, lungs, and oral lesions (N = 80) from severely or fatally infected animals were 123 presented for analysis by RT-qPCR with spleen and lymph nodes being most abundant. The relative sensitivity and specificity of the cELISA were estimated from the 2x2 228 contingency table (Table 1) the cut-off (Fig. 4) . The frequency distribution profile of Ct-values from the tissue samples 295 was very similar to the profile of the blood samples of sheep with the exception that the viral 296 RNA load in the tissue samples was generally lower (Fig. 4 ). Compared to other tissue 297 samples, best results were obtained with spleen and lymph nodes. profiling results (see below). All together, the present study clearly suggests that the number 364 of false-negative RT-qPCR results is rather low. Although it is impossible to estimate the 365 number of combined cELISA/RT-qPCR false-negatives in case of early infections, the 366 number is most probably also very low as in the majority of cases BTV RNA can already be 367 detected before the onset of clinical signs (MacLachlan, 2004) . 368
369
In sheep 66% of the notified cases were confirmed by cELISA, whereas in cattle 50% of the 370 cases were apparently misdiagnosed on the basis of clinical signs (Fig. 2B ). This percentage 371 the Ct-values displayed a bimodal shape characteristic of an infected population (Fig 4) . In 413 contrast to the cELISA, the position of the positive mode differed depending on the host 414 species. This finding supports our statement that profiling gives more information than a 415 dichotomised (pos/neg) analysis used to calculate sensitivity and specificity and showing no 416 difference between both species. In general, the virus accumulated to higher levels in the 417 blood of sheep than that of cattle. This might explain the higher case fatality in sheep (42%) 418 compared to cattle (18%) during the epidemic. 419
The Ct distribution profile of the tissue samples was similar to that observed for blood 420 samples but with the peak corresponding to positive animals slightly shifted towards the right 421 ( Fig. 4 ). This suggests a lower viral load in or viral RNA recovery from tissue samples. Since 422 the presented tissue samples were frequently of poor quality, as judged by the internal beta-423 actin control, this difference could at least in part be due to the degradation of the viral RNA. will certainly remain BTV-positive by RT-qPCR for more than one month. To avoid any 440 unnecessary analysis it would, therefore, be more appropriate to only retest these animals after 441 2 to 3 months. It is, however, also important to point out that the detection of viral RNA is not 442 always sufficient to determine the infectious status of the animal (MacLachlan, 2004). Since 443 the RT-qPCR used in this study is at least 100 times more sensitive than virus isolation 444 
